Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Generation Bio (GBIO) EBITDA (2022 - 2025)

Historic EBITDA for Generation Bio (GBIO) over the last 4 years, with Q3 2025 value amounting to -$5.5 million.

  • Generation Bio's EBITDA rose 6251.19% to -$5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$62.9 million, marking a year-over-year increase of 5663.9%. This contributed to the annual value of -$131.8 million for FY2024, which is 437.84% down from last year.
  • Per Generation Bio's latest filing, its EBITDA stood at -$5.5 million for Q3 2025, which was up 6251.19% from -$21.0 million recorded in Q2 2025.
  • Over the past 5 years, Generation Bio's EBITDA peaked at -$5.5 million during Q3 2025, and registered a low of -$75.0 million during Q1 2024.
  • Moreover, its 4-year median value for EBITDA was -$29.7 million (2023), whereas its average is -$28.7 million.
  • As far as peak fluctuations go, Generation Bio's EBITDA tumbled by 13458.11% in 2024, and later skyrocketed by 8016.85% in 2025.
  • Over the past 4 years, Generation Bio's EBITDA (Quarter) stood at -$32.2 million in 2022, then decreased by 8.46% to -$34.9 million in 2023, then skyrocketed by 38.29% to -$21.5 million in 2024, then surged by 74.39% to -$5.5 million in 2025.
  • Its EBITDA stands at -$5.5 million for Q3 2025, versus -$21.0 million for Q2 2025 and -$14.9 million for Q1 2025.